You'll see more women taking Evista (raloxifene) to TREAT osteoporosis

You'll see more women taking Evista (raloxifene) to TREAT osteoporosis. It was initially approved for prevention...but new research shows it's also effective for treatment.

In fact, Evista is now approved in the U.S. for treatment.

Evista decreases vertebral fractures up to postmenopausal women who take it for 3 years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote